It stresses the urgent need for clinicians to differentiate this condition from other forms of angioedema, particularly mast cell-mediated types, as early recognition and long-term monitoring are crucial given the possibility of recurrence even after discontinuation of ACE inhibitors. Here, ACE is linked to angioedema.